世界の脂肪肉腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Liposarcoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3436 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、脂肪肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、外科療法）、用途別市場規模（病院、専門クリニック、がん治療・リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脂肪肉腫治療の市場動向 ・企業の競争状況、市場シェア ・脂肪肉腫治療の種類別市場規模（化学療法、放射線療法、外科療法） ・脂肪肉腫治療の用途別市場規模（病院、専門クリニック、がん治療・リハビリテーションセンター） ・脂肪肉腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・脂肪肉腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脂肪肉腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脂肪肉腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脂肪肉腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Pfizer、Eli Lilly、Sanofi SA、Novartis AG、Baxter International、Bristol Laboratories、Teva Pharmaceutical Industries、Mylan N.V、Actavis、Fresenius Kabi、Accord Healthcare、Taro Pharmaceuticals、Sandoz、Bedford Laboratories） ・結論

Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs.
Surgical therapy treatment segment is expected to account for major share in global liposarcoma treatment market as it is the choice of treatment recommended by majority of cancer specialists. Most of the physicians do not rely on chemotherapy for the liposarcoma treatment however, it can be used prior to the surgery to reduce the size of the tumor making it the second largest segment in terms of value in global liposarcoma treatment market. Radiation therapy treatment is used to avoid recurrence of the liposarcoma after surgery and contributes a minimal share in global liposarcoma treatment market.

Market Analysis and Insights: Global Liposarcoma Treatment Market
The global Liposarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liposarcoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liposarcoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liposarcoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liposarcoma Treatment market.

Global Liposarcoma Treatment Scope and Market Size
Liposarcoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liposarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Surgical Therapy

Segment by Application
Hospitals
Multispecialty Clinics
Cancer Treatment and Rehabilitation Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Pfizer
Eli Lilly
Sanofi SA
Novartis AG
Baxter International
Bristol Laboratories
Teva Pharmaceutical Industries
Mylan N.V
Sanofi SA
Novartis AG
Accord Healthcare
Taro Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposarcoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Surgical Therapy
1.3 Market by Application
1.3.1 Global Liposarcoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Multispecialty Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Liposarcoma Treatment Market Perspective (2016-2027)
2.2 Liposarcoma Treatment Growth Trends by Regions
2.2.1 Liposarcoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liposarcoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Liposarcoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Liposarcoma Treatment Industry Dynamic
2.3.1 Liposarcoma Treatment Market Trends
2.3.2 Liposarcoma Treatment Market Drivers
2.3.3 Liposarcoma Treatment Market Challenges
2.3.4 Liposarcoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Liposarcoma Treatment Players by Revenue
3.1.1 Global Top Liposarcoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Liposarcoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Liposarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liposarcoma Treatment Revenue
3.4 Global Liposarcoma Treatment Market Concentration Ratio
3.4.1 Global Liposarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposarcoma Treatment Revenue in 2020
3.5 Liposarcoma Treatment Key Players Head office and Area Served
3.6 Key Players Liposarcoma Treatment Product Solution and Service
3.7 Date of Enter into Liposarcoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Liposarcoma Treatment Breakdown Data by Type
4.1 Global Liposarcoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Liposarcoma Treatment Forecasted Market Size by Type (2022-2027)

5 Liposarcoma Treatment Breakdown Data by Application
5.1 Global Liposarcoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Liposarcoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Liposarcoma Treatment Market Size (2016-2027)
6.2 North America Liposarcoma Treatment Market Size by Type
6.2.1 North America Liposarcoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Liposarcoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Liposarcoma Treatment Market Size by Type (2016-2027)
6.3 North America Liposarcoma Treatment Market Size by Application
6.3.1 North America Liposarcoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Liposarcoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Liposarcoma Treatment Market Size by Application (2016-2027)
6.4 North America Liposarcoma Treatment Market Size by Country
6.4.1 North America Liposarcoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Liposarcoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Liposarcoma Treatment Market Size (2016-2027)
7.2 Europe Liposarcoma Treatment Market Size by Type
7.2.1 Europe Liposarcoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Liposarcoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Liposarcoma Treatment Market Size by Type (2016-2027)
7.3 Europe Liposarcoma Treatment Market Size by Application
7.3.1 Europe Liposarcoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Liposarcoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Liposarcoma Treatment Market Size by Application (2016-2027)
7.4 Europe Liposarcoma Treatment Market Size by Country
7.4.1 Europe Liposarcoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Liposarcoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Liposarcoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Liposarcoma Treatment Market Size by Type
8.2.1 Asia-Pacific Liposarcoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liposarcoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liposarcoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Liposarcoma Treatment Market Size by Application
8.3.1 Asia-Pacific Liposarcoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liposarcoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liposarcoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Liposarcoma Treatment Market Size by Region
8.4.1 Asia-Pacific Liposarcoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liposarcoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Liposarcoma Treatment Market Size (2016-2027)
9.2 Latin America Liposarcoma Treatment Market Size by Type
9.2.1 Latin America Liposarcoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Liposarcoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Liposarcoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Liposarcoma Treatment Market Size by Application
9.3.1 Latin America Liposarcoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Liposarcoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Liposarcoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Liposarcoma Treatment Market Size by Country
9.4.1 Latin America Liposarcoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Liposarcoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Liposarcoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Liposarcoma Treatment Market Size by Type
10.2.1 Middle East & Africa Liposarcoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liposarcoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liposarcoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Liposarcoma Treatment Market Size by Application
10.3.1 Middle East & Africa Liposarcoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liposarcoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liposarcoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Liposarcoma Treatment Market Size by Country
10.4.1 Middle East & Africa Liposarcoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liposarcoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Liposarcoma Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Liposarcoma Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Liposarcoma Treatment Introduction
11.2.4 Pfizer Revenue in Liposarcoma Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Liposarcoma Treatment Introduction
11.3.4 Eli Lilly Revenue in Liposarcoma Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Sanofi SA
11.4.1 Sanofi SA Company Details
11.4.2 Sanofi SA Business Overview
11.4.3 Sanofi SA Liposarcoma Treatment Introduction
11.4.4 Sanofi SA Revenue in Liposarcoma Treatment Business (2016-2021)
11.4.5 Sanofi SA Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Liposarcoma Treatment Introduction
11.5.4 Novartis AG Revenue in Liposarcoma Treatment Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Liposarcoma Treatment Introduction
11.6.4 Baxter International Revenue in Liposarcoma Treatment Business (2016-2021)
11.6.5 Baxter International Recent Development
11.7 Bristol Laboratories
11.7.1 Bristol Laboratories Company Details
11.7.2 Bristol Laboratories Business Overview
11.7.3 Bristol Laboratories Liposarcoma Treatment Introduction
11.7.4 Bristol Laboratories Revenue in Liposarcoma Treatment Business (2016-2021)
11.7.5 Bristol Laboratories Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Liposarcoma Treatment Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Liposarcoma Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Mylan N.V
11.9.1 Mylan N.V Company Details
11.9.2 Mylan N.V Business Overview
11.9.3 Mylan N.V Liposarcoma Treatment Introduction
11.9.4 Mylan N.V Revenue in Liposarcoma Treatment Business (2016-2021)
11.9.5 Mylan N.V Recent Development
11.10 Actavis
11.10.1 Actavis Company Details
11.10.2 Actavis Business Overview
11.10.3 Actavis Liposarcoma Treatment Introduction
11.10.4 Actavis Revenue in Liposarcoma Treatment Business (2016-2021)
11.10.5 Actavis Recent Development
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Details
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Liposarcoma Treatment Introduction
11.11.4 Fresenius Kabi Revenue in Liposarcoma Treatment Business (2016-2021)
11.11.5 Fresenius Kabi Recent Development
11.12 Accord Healthcare
11.12.1 Accord Healthcare Company Details
11.12.2 Accord Healthcare Business Overview
11.12.3 Accord Healthcare Liposarcoma Treatment Introduction
11.12.4 Accord Healthcare Revenue in Liposarcoma Treatment Business (2016-2021)
11.12.5 Accord Healthcare Recent Development
11.13 Taro Pharmaceuticals
11.13.1 Taro Pharmaceuticals Company Details
11.13.2 Taro Pharmaceuticals Business Overview
11.13.3 Taro Pharmaceuticals Liposarcoma Treatment Introduction
11.13.4 Taro Pharmaceuticals Revenue in Liposarcoma Treatment Business (2016-2021)
11.13.5 Taro Pharmaceuticals Recent Development
11.14 Sandoz
11.14.1 Sandoz Company Details
11.14.2 Sandoz Business Overview
11.14.3 Sandoz Liposarcoma Treatment Introduction
11.14.4 Sandoz Revenue in Liposarcoma Treatment Business (2016-2021)
11.14.5 Sandoz Recent Development
11.15 Bedford Laboratories
11.15.1 Bedford Laboratories Company Details
11.15.2 Bedford Laboratories Business Overview
11.15.3 Bedford Laboratories Liposarcoma Treatment Introduction
11.15.4 Bedford Laboratories Revenue in Liposarcoma Treatment Business (2016-2021)
11.15.5 Bedford Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Liposarcoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Surgical Therapy
Table 5. Global Liposarcoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Liposarcoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Liposarcoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Liposarcoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Liposarcoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Liposarcoma Treatment Market Share by Regions (2022-2027)
Table 11. Liposarcoma Treatment Market Trends
Table 12. Liposarcoma Treatment Market Drivers
Table 13. Liposarcoma Treatment Market Challenges
Table 14. Liposarcoma Treatment Market Restraints
Table 15. Global Liposarcoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Liposarcoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Liposarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposarcoma Treatment as of 2020)
Table 18. Ranking of Global Top Liposarcoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Liposarcoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Liposarcoma Treatment Product Solution and Service
Table 22. Date of Enter into Liposarcoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Liposarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Liposarcoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Liposarcoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Liposarcoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Liposarcoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Liposarcoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Liposarcoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Liposarcoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Liposarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Liposarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Liposarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Liposarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Liposarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Liposarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Liposarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Liposarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Liposarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Liposarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Liposarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Liposarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Liposarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Liposarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Liposarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Liposarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Liposarcoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Liposarcoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Liposarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Liposarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Liposarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Liposarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Liposarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Liposarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Liposarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Liposarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Liposarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Liposarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Liposarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Liposarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Liposarcoma Treatment Product
Table 65. Johnson & Johnson Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Liposarcoma Treatment Product
Table 70. Pfizer Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Liposarcoma Treatment Product
Table 75. Eli Lilly Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Sanofi SA Company Details
Table 78. Sanofi SA Business Overview
Table 79. Sanofi SA Liposarcoma Treatment Product
Table 80. Sanofi SA Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Sanofi SA Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Liposarcoma Treatment Product
Table 85. Novartis AG Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Baxter International Company Details
Table 88. Baxter International Business Overview
Table 89. Baxter International Liposarcoma Treatment Product
Table 90. Baxter International Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Baxter International Recent Development
Table 92. Bristol Laboratories Company Details
Table 93. Bristol Laboratories Business Overview
Table 94. Bristol Laboratories Liposarcoma Treatment Product
Table 95. Bristol Laboratories Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 96. Bristol Laboratories Recent Development
Table 97. Teva Pharmaceutical Industries Company Details
Table 98. Teva Pharmaceutical Industries Business Overview
Table 99. Teva Pharmaceutical Industries Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 100. Teva Pharmaceutical Industries Recent Development
Table 101. Mylan N.V Company Details
Table 102. Mylan N.V Business Overview
Table 103. Mylan N.V Liposarcoma Treatment Product
Table 104. Mylan N.V Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 105. Mylan N.V Recent Development
Table 106. Actavis Company Details
Table 107. Actavis Business Overview
Table 108. Actavis Liposarcoma Treatment Product
Table 109. Actavis Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 110. Actavis Recent Development
Table 111. Fresenius Kabi Company Details
Table 112. Fresenius Kabi Business Overview
Table 113. Fresenius Kabi Liposarcoma Treatment Product
Table 114. Fresenius Kabi Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 115. Fresenius Kabi Recent Development
Table 116. Accord Healthcare Company Details
Table 117. Accord Healthcare Business Overview
Table 118. Accord Healthcare Liposarcoma Treatment Product
Table 119. Accord Healthcare Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 120. Accord Healthcare Recent Development
Table 121. Taro Pharmaceuticals Company Details
Table 122. Taro Pharmaceuticals Business Overview
Table 123. Taro Pharmaceuticals Liposarcoma Treatment Product
Table 124. Taro Pharmaceuticals Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 125. Taro Pharmaceuticals Recent Development
Table 126. Sandoz Company Details
Table 127. Sandoz Business Overview
Table 128. Sandoz Liposarcoma Treatment Product
Table 129. Sandoz Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 130. Sandoz Recent Development
Table 131. Bedford Laboratories Company Details
Table 132. Bedford Laboratories Business Overview
Table 133. Bedford Laboratories Liposarcoma Treatment Product
Table 134. Bedford Laboratories Revenue in Liposarcoma Treatment Business (2016-2021) & (US$ Million)
Table 135. Bedford Laboratories Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liposarcoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Surgical Therapy Features
Figure 5. Global Liposarcoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Multispecialty Clinics Case Studies
Figure 8. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 9. Liposarcoma Treatment Report Years Considered
Figure 10. Global Liposarcoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Liposarcoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Liposarcoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Liposarcoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Liposarcoma Treatment Market Share by Players in 2020
Figure 15. Global Top Liposarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposarcoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Liposarcoma Treatment Revenue in 2020
Figure 17. Global Liposarcoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Liposarcoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Liposarcoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Liposarcoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Liposarcoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Liposarcoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Liposarcoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Liposarcoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Liposarcoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Liposarcoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Liposarcoma Treatment Market Share by Region (2016-2027)
Figure 39. China Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Liposarcoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Liposarcoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Liposarcoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Liposarcoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Liposarcoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Liposarcoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Liposarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 61. Sanofi SA Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 63. Baxter International Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 64. Bristol Laboratories Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 66. Mylan N.V Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 67. Actavis Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 68. Fresenius Kabi Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 69. Accord Healthcare Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 70. Taro Pharmaceuticals Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 71. Sandoz Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 72. Bedford Laboratories Revenue Growth Rate in Liposarcoma Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---